HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Olivia Wendling Selected Research

BMS453

5/2003Retinoic acid-induced developmental defects are mediated by RARbeta/RXR heterodimers in the pharyngeal endoderm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Olivia Wendling Research Topics

Disease

1Cardiomegaly (Heart Hypertrophy)
11/2015
1Fibrosis (Cirrhosis)
11/2015
1Ventricular Dysfunction
11/2015
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2015
1Atherosclerotic Plaque (Atheroma)
04/2007
1Neoplasms (Cancer)
02/2005
1Aberrant Crypt Foci
02/2005
1Obesity
03/2004
1Tetraploidy
03/2004
1Fetal Diseases (Embryopathy)
05/2003

Drug/Important Bio-Agent (IBA)

1RS 127445IBA
11/2015
1Serotonin (5 Hydroxytryptamine)IBA
11/2015
15-HT2B Serotonin ReceptorIBA
11/2015
1PolysaccharidesIBA
04/2007
1LipidsIBA
04/2007
1CollagenIBA
04/2007
1Cholesterol Esters (Cholesteryl Esters)IBA
04/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2005
1AzoxymethaneIBA
02/2005
1PPAR gammaIBA
03/2004
1BMS453IBA
05/2003
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2003
1retinoic acid receptor betaIBA
05/2003